Parenteral Drugs (India) Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 23.5 million compared to INR 46.41 million a year ago. Revenue was INR 23.61 million compared to INR 46.55 million a year ago. Net loss was INR 336.13 million compared to INR 336.74 million a year ago. Basic loss per share from continuing operations was INR 11.28 compared to INR 11.31 a year ago. Diluted loss per share from continuing operations was INR 11.28 compared to INR 11.31 a year ago.
For the six months, sales was INR 52.81 million compared to INR 75.6 million a year ago. Revenue was INR 53.03 million compared to INR 75.86 million a year ago. Net loss was INR 656.5 million compared to INR 658.93 million a year ago. Basic loss per share from continuing operations was INR 22.01 compared to INR 22.14 a year ago. Diluted loss per share from continuing operations was INR 22.01 compared to INR 22.14 a year ago.